Skip to content

Improved Accessibility to the Renal Transplant List

ARS Experimentation Project: Improving Accessibility to the Renal Transplantation List

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03934554
Acronym
2ALTR
Enrollment
125
Registered
2019-05-02
Start date
2018-09-01
Completion date
2020-12-30
Last updated
2020-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic End Stage Renal Failure

Keywords

Nephrology, Kidney transplant, Registration, Transplant waiting list

Brief summary

In 2014, the States General of Kidney have allowed to assess the situation concerning the management of chronic kidney disease on the national territory. Ex-Languedoc-Roussillon has emerged as one of the French regions with a high dialysis / transplant ratio compared to other regions. Disparities in accessibility to the kidney transplant list were also very important. In the ex-Languedoc-Roussillon Region, the number of patients on the renal transplant list was lower than the national average (18.9 vs. 24.1%, respectively, according to the REIN 2015 report). In 2015, the Regional Health Agency (ARS) ex-Languedoc-Roussillon, has published proposals to improve the healthcare of the patient in chronic end stage renal failure, and accessibility to the national waiting list for renal transplantation (CRISTAL). To increase accessibility to the national waiting list for renal transplantation by improving the patient's healthcare, our project is based on the creation of a reinforced exchanges connexion between the hospital's nephrology services professionals, dialysis units and liberal nephrologists. This will include having regular meetings between dialysis nephrologists and CHU nephrologists. The proposals for this project were: 1. to organize multidisciplinary consultation meetings between transplant and dialysis professionals 2. to set up an exchange platform and communication tools built on the model of telemedicine (COVOTEM), common to the nephrology departments of the University Hospital Center, dialysis units. This new device for the management of chronic end stage renal failure should increase the number of patients on the national renal transplantation waiting list. It should also make it possible to reduce the time between: firstly, the sending of the pre-registration file to the transplantation at Montpellier University Hospital and registration, and secondly between dialysis and registration.on waiting list. The investigators hope that this experiment will increase the number of registrations on the National Kidney Transplantation Waitlist (CRISTAL). The implementation of this innovative tool should facilitate communication between nephrologists dialysis centers and nephrologists of CHU Montpellier, and accelerate the process of registration on the National Kidney Transplantation Waitlist. If this platform proves to be easy to use and if the project's evaluation criteria show significant results, the platform could then be used to monitor patients in post-transplantation. Indeed, the data of patients who perform an alternating follow-up would be available for the referring nephrologists and for the transplant center. The further development of the platform would allow to create a mode of communication via this platform.

Detailed description

Main Objective: Evolution of the number of patients, dialysed or not dialysed in the ex-Languedoc-Roussillon Region, acceding during the year, to a pre-transplant assessment for a registration on the national renal transplantation waiting list ( CRISTAL). Secondary Objectives: * Evolution of patient waiting times for registration on the national renal transplantation waiting list (CRISTAL) * For incident cases: Evolution of the time between dialysis, and the date of registration on the transplant waiting list or the date of decision of temporary or definitive contraindication by nephrologists CHU Montpellier . * Evolution of the delays between the date of reception of the pre-registration file by the nephrology department of the University Hospital and the closing date of the file (either a definitive inscription, a definitive contraindication or a temporary contraindication \> 4 months) * Evolution of the number of multidisciplinary consultation meetings performed without videoconferencing and videoconferencing between the dialysis center and Montpellier University Hospital * Evaluation of exchanges between professionals involved in the course of care of the patient in chronic end stage renal failure

Interventions

None listed

Sponsors

Aider Montpellier : Dr Chalabi Lofti
CollaboratorUNKNOWN
Aider Cèvennes et Confins Rhodaniens : Dr Mohajer Médérick
CollaboratorUNKNOWN
Aider Nîmes : Philippe LAN YUE WAH
CollaboratorUNKNOWN
Aider Lozère : Dr Hélène LERAY / Dr Cécile TURC-BARON
CollaboratorUNKNOWN
Aider Perpignan : Dr Ahmed RACHI
CollaboratorUNKNOWN
CHU de Nîmes : Pr Moranne Olivier
CollaboratorUNKNOWN
CH de Perpignan : Dr Vela Carlos
CollaboratorUNKNOWN
Centre d'Hémodialyse St Guilhem : Dr Argilès Angèl
CollaboratorUNKNOWN
Clinique Médipôle Perpignan : Dr DECOURT Alexandre
CollaboratorUNKNOWN
Clinique de Narbonne : Dr De Cornélissen François
CollaboratorUNKNOWN
GCS Help : Dr Maria Eugenia Noguera Gonzales
CollaboratorUNKNOWN
NephroCare Castelnau / Mas du Rochet / Lunel : Dr Basel Olivia
CollaboratorUNKNOWN
NephroCare Béziers : Dr Baron Emmanuel
CollaboratorUNKNOWN
NephroCare Nîmes / Bagnols : Dr Rousseau Philippe
CollaboratorUNKNOWN
Villeneuve les Béziers : Dr Baron Emmanuel
CollaboratorUNKNOWN
GCS eSanté : Sylvain Collet
CollaboratorUNKNOWN
University Hospital, Montpellier
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Dialysis or non-dialysis patients with chronic renal insufficiency with a GFR \< 20ml / min eligible for transplant * Patient wishing to start the registration process at the transplant * Patient giving consent for the transmission of his data via an electronic platform

Exclusion criteria

* Patient already enrolled * Patient having a pathology with a life expectancy of less than two years * Patient with serious psychiatric disorders , or dementia.

Design outcomes

Primary

MeasureTime frameDescription
Number of patient dialysed or not dialysed acceding to a pre-transplant assessment for a registration on the national renal transplantation waiting list ( CRISTAL).1 year, up to the end of studyNumber of patient dialysed or not dialysed acceding to a pre-transplant assessment for a registration on the national renal transplantation waiting list ( CRISTAL).

Secondary

MeasureTime frameDescription
Number of files received by the nephrology department of Montpellier University Hospital on the COVOTEM platform1 year, up to the end of studyNumber of files received by the nephrology department of Montpellier University Hospital on the COVOTEM platform
Number of dialysis patients who had a pre-transplant evaluation1 year, up to the end of studyNumber of dialysis patients who had a pre-transplant evaluation
Number of non-dialysis patients who had a pre-transplant evaluation1 year, up to the end of studyNumber of non-dialysis patients who had a pre-transplant evaluation
Number of patients on temporary or definitive contraindications1 year, up to the end of studyNumber of patients on temporary or definitive contraindications
Average period between the reception of the pre-registration file by the nephrology department of the University Hospital of Montpellier and the consultation appointment for registration1 year, up to the end of studyAverage period between the reception of the pre-registration file by the nephrology department of the University Hospital of Montpellier and the consultation appointment for registration
Average period between the dialysis of the patient and the reception of the pre-registration file by the nephrology department of Montpellier University Hospital1 year, up to the end of studyAverage period between the dialysis of the patient and the reception of the pre-registration file by the nephrology department of Montpellier University Hospital
Rate of participation of the centers in the experimentation (Number of files received by the nephrology department of the University Hospital Center of Montpellier per center)1 year, up to the end of studyRate of participation of the centers in the experimentation (Number of files received by the nephrology department of the University Hospital Center of Montpellier per center)
Number of multidisciplinary consultation meetings performed without videoconferencing or videoconferencing between the dialysis center and Montpellier University Hospital Center1 year, up to the end of studyNumber of multidisciplinary consultation meetings performed without videoconferencing or videoconferencing between the dialysis center and Montpellier University Hospital Center
Average period between the consultation appointment and the closing of the file (either a definitive inscription, a definitive contraindication, or a temporary contraindication > 4months1 year, up to the end of studyAverage period between the consultation appointment and the closing of the file (either a definitive inscription, a definitive contraindication, or a temporary contraindication \> 4months
Number of non-dialysis patients with renal insufficiency enrolled preemptively on the national renal transplantation waiting list1 year, up to the end of studyNumber of non-dialysis patients with renal insufficiency enrolled preemptively on the national renal transplantation waiting list
Average period between the reception of the pre-registration file1 year, up to the end of studyAverage period between the reception of the pre-registration file by the nephrology department of the CHU of Montpellier and the closing of the file (either a definitive inscription, a definitive contraindication, or a temporary contraindication \> 4months)

Countries

France

Contacts

Primary ContactMoglie Le Quintrec, Professor
m-lequintrec-donnette@chu-montpellier.fr04 67 33 09 96

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026